SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001558370-23-014935
Filing Date
2023-08-14
Accepted
2023-08-14 17:29:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC TO-C hrmy-20220520xsctoc.htm SC TO-C 80188
2 EX-2.1 hrmy-20220520xex2d1.htm EX-2.1 1031199
3 EX-99.1 hrmy-20220520xex99d1.htm EX-99.1 121734
4 EX-99.2 hrmy-20220520xex99d2.htm EX-99.2 47923
5 GRAPHIC hrmy-20220520xex99d1001.jpg GRAPHIC 747
6 GRAPHIC hrmy-20220520xex99d2001.jpg GRAPHIC 9992
7 GRAPHIC hrmy-20220520xsctoc001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-23-014935.txt   1299675
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88971 | Film No.: 231172229
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filed by) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations